e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis
Maron-Gutierrez T., Castiglione R.C., Xisto D.G., Oliveira M.G., Cruz F.F., Peçanha R., Carreira-Junior H., Ornellas D.S., Moraes M.O., Takiya C.M., Rocco P.R.M., Morales M.M.
Source:
Eur Respir J 2011; 37: 1217-1225
Journal Issue:
May
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Maron-Gutierrez T., Castiglione R.C., Xisto D.G., Oliveira M.G., Cruz F.F., Peçanha R., Carreira-Junior H., Ornellas D.S., Moraes M.O., Takiya C.M., Rocco P.R.M., Morales M.M.. Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis. Eur Respir J 2011; 37: 1217-1225
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The physiology of breathlessness
Basics of respiratory drive and respiratory mechanics
Respiratory mechanics: changes in disease
Related content which might interest you:
Bone marrow-derived mononuclear cell therapy reduces lung and distal organ damage in severe sepsis
Source: Annual Congress 2010 - Acute lung injury and ventilator-induced lung injury
Year: 2010
Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Bone marrow stromal cell conditioned media reduces endoplasmic reticulum stress in alveolar epithelial cells in vitro
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Collagen VI-producing macrophages mediate lung fibrosis
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension
Source: Eur Respir J 2010; 36: 1209-1211
Year: 2010
Impaired migration of bone marrow mesenchymal stem cells in COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction
Source: Eur Respir J 2012; 40: 424-435
Year: 2012
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009
Effect of intratracheal transplantation of bone marrow-derived endothelial progenitor cell on cigarette smoking-induced emphysema in mice
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Injection of bone marrow cells reduces bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
Intratracheal administration of bone marrow-derived mesenchymal stem cells ameliorates lung function
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
Role of macrophage activation in type II alveolar cells transplantation for the treatment of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma
Source: Eur Respir J 2011; 38: 679-687
Year: 2011
Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Effects of bone marrow mesenchymal stem cells on bleomycin induced pulmonary fibrosis in rats
Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches
Year: 2006
The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway
Source: International Congress 2014 – ILDs 1
Year: 2014
Modulation of lung CD11c+ dendritic cells by TGF-β in pulmonary fibrosis in mice
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Uncoupling the pro-fibrotic effects of TGF-beta1 versus tissue hardening in lung fibroblasts
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Cell therapy with adipose tissue-derived stem/stromal cells for elastase-induced pulmonary emphysema in rats
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept